Bosnalijek d.d. Sarajevo Logo

Bosnalijek d.d. Sarajevo

Global manufacturer of drugs for digestive, metabolic, and cardiovascular health.

BSNL | SASE

Overview

Corporate Details

ISIN(s):
BABSNLR00005
LEI:
Country:
Bosnia and Herzegovina
Address:
Jukićeva 53, 71000 Sarajevo
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Established in 1951, Bosnalijek is a major industrial manufacturer of pharmaceuticals. The company develops and produces a wide portfolio of high-quality medications for peroral, parenteral, and topical applications, targeting conditions related to the digestive system, metabolism, and cardiovascular system. With a presence in more than 20 international markets, Bosnalijek's quality assurance system adheres to stringent national and international Good Manufacturing Practice (GMP) standards. The company's strategy is centered on modernizing its facilities, advancing knowledge, and investing in new technologies to drive innovation within the industry.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Bosnalijek d.d. Sarajevo filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Bosnalijek d.d. Sarajevo

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Bosnalijek d.d. Sarajevo via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Develops approved cannabinoid medicines for pain, epilepsy, and heart failure.
United Kingdom
ANAN
Develops qPCR diagnostic kits and robotic automation systems for clinical and research laboratories.
Türkiye
ANGEN
ANAVEX LIFE SCIENCES CORP. Logo
Developing precision therapeutics for neurodegenerative and CNS disorders.
United States of America
AVXL
Anbio Biotechnology Logo
Develops and supplies in vitro diagnostic solutions for human and veterinary markets.
United States of America
NNNN
Anebulo Pharmaceuticals, Inc. Logo
Clinical-stage biotech developing an antidote for acute cannabinoid intoxication in ER patients.
United States of America
ANEB
AnGes, Inc. Logo
Develops gene-based medicines like HGF gene therapy, DNA vaccines, and NF-kB decoys.
Japan
4563
Anika Therapeutics, Inc. Logo
Develops joint preservation and regenerative solutions for early intervention orthopedic care.
United States of America
ANIK
ANIMALCARE GROUP PLC Logo
Develops & sells veterinary prescription & OTC medicines for professionals worldwide.
United Kingdom
ANCR
ANI PHARMACEUTICALS INC Logo
Develops, manufactures, and markets branded/generic drugs and OTCs for niche therapeutic areas.
United States of America
ANIP
Annexin Pharmaceuticals AB Logo
Developing Annexin A5 protein to treat vascular, inflammatory, and cancerous diseases.
Sweden
ANNX

Talk to a Data Expert

Have a question? We'll get back to you promptly.